FDA approves new respiratory virus test

Jan 21, 2008

The U.S. Food and Drug Administration has approved a test that detects four respiratory viruses, including the flu, in a patient's respiratory secretions.

The ProFlu+ test provides results in as few as three hours. The FDA said other diagnostic tests for respiratory viruses are fast but not as accurate, or are as accurate but odn't givce results as quickly.

The real-time test employs a multiplex platform that allows several tests to be processed simultaneously using the same sample to detect influenza A virus, influenza B virus and respiratory syncytial virus A and B. Those viruses, said the FDA, can cause influenza, an infection of the airways called bronchiolitis, and pneumonia.

"Antiviral drugs are most effective when initiated within the first two days of symptoms," said Dr. Daniel Schultz, director of the FDA's Center for Devices and Radiological Health. "This new test, which is part of the new era of molecular medicine, can help the medical community quickly determine whether a respiratory illness is caused by one of these four viruses and initiate the appropriate treatment."

ProFlu+ is manufactured by Prodesse Inc. of Milwaukee.

Copyright 2008 by United Press International

Explore further: Cambodia bans 'virgin surgery' adverts

add to favorites email to friend print save as pdf

Related Stories

Mutating virus suppresses cow's immune response

Sep 04, 2014

Bovine viral diarrhea virus infections result in one of the most costly diseases among cattle with losses in U.S. herds estimated at $2 billion per year, according to professor Christopher Chase of the South ...

Recommended for you

Cambodia bans 'virgin surgery' adverts

2 hours ago

The Cambodian government has ordered a hospital to stop advertising so-called virginity restoration procedures, saying it harms the "morality" of society.

What's happening with your donated specimen?

17 hours ago

When donating blood, plasma, human tissue or any other bodily sample for medical research, most people might not think about how it's being used. But if you were told, would you care?

Amgen tops Street 4Q forecasts

Jan 27, 2015

Amgen Inc. cruised to a 27 percent jump in fourth-quarter profit and beat Wall Street expectations, due to higher sales of nearly all its medicines, tight cost controls and a tax benefit.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.